MedPath
NMPA Approval

Lenvatinib Mesilate Capsules

国药准字H20253427

February 20, 2025

Drug Information

甲磺酸仑伐替尼胶囊

胶囊剂

4mg(按C₂₁H₁₉ClN₄O₄计)

化学药品

February 20, 2025

Company Information

Applicant Company

南京市栖霞区仙林街道纬地路9号江苏生命科技创新园C6栋603室

Manufacturing Company

江苏省泗阳县长江路21号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸仑伐替尼胶囊 - NMPA 批准文号 | MedPath